SCHEMBL19974426

SCHEMBL19974426

c1ccc2c(c1)-c1ccccc1C21c2ccccc2-c2cccc3cccc1c23

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.54
HSD17B10 Q99714 6/20 0.54
MAPK1 P28482 4/20 0.54
TSHR P16473 4/20 0.54
ATM Q13315 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
HPGD P15428 4/20 0.48
CASP1 P29466 3/20 0.48
CASP7 P55210 2/20 0.48
HIF1A Q16665 2/20 0.48
TP53 P04637 1/20 0.48
CYP3A4 P08684 2/20 0.43
PABPC1 P11940 1/20 0.43
DNMT1 P26358 1/20 0.43
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
OPRK1 P41145 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29516015 1.00 ALDH1A1 (0.54) ALDH1A1HSD17B10MAPK1TSHRATM
SCHEMBL18814822 0.93 ALDH1A1 (0.50) ALDH1A1HSD17B10MAPK1TSHRATM
SCHEMBL22646598 0.91 ALDH1A1 (0.48) ALDH1A1HSD17B10MAPK1TSHRATM
SCHEMBL29762005 0.89 ALDH1A1 (0.46) ALDH1A1HSD17B10MAPK1TSHRATM
SCHEMBL25303926 0.89 ALDH1A1 (0.43) ALDH1A1HSD17B10MAPK1TSHRATM
SCHEMBL23518187 0.87 MAPK1 (0.42) ALDH1A1HSD17B10MAPK1TSHRATM
SCHEMBL19567026 0.84 MAPK1 (0.39) ALDH1A1HSD17B10MAPK1TSHRATM
SCHEMBL17283592 0.84 MAPK1 (0.40) ALDH1A1HSD17B10MAPK1TSHRATM
SCHEMBL23430653 0.84 SMN1; SMN2 (0.47) ALDH1A1HSD17B10MAPK1TSHRATM
SCHEMBL21701228 0.84 PDK2 (0.46) ALDH1A1HSD17B10MAPK1TSHRATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4691210-A1 ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING A ORGANIC MATRIX COMPOUND AND ORGANIC ELECTRON TRANSPORT COMPOUND OF FORMULA (I), AND DISPLAY DEVICE COMPRISING THE ORGANIC ELECTROLUMINESCENT DEVICE Novaled GmbH (DE) 2026-02-11 EP claimed
WO-2024208890-A1 ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING A ORGANIC MATRIX COMPOUND AND ORGANIC ELECTRON TRANSPORT COMPOUND OF FORMULA (I), AND DISPLAY DEVICE COMPRISING THE ORGANIC ELECTROLUMINESCENT DEVICE NOVALED GMBH (DE) 2024-10-10 WO claimed
EP-4444061-A1 ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING A ORGANIC MATRIX COMPOUND AND ORGANIC ELECTRON TRANSPORT COMPOUND OF FORMULA (I), AND DISPLAY DEVICE COMPRISING THE ORGANIC ELECTROLUMINESCENT DEVICE Novaled GmbH (DE) 2024-10-09 EP claimed
EP-3898606-A1 COMPOUND AND AN ORGANIC SEMICONDUCTING LAYER, AN ORGANIC ELECTRONIC DEVICE AND A DISPLAY DEVICE COMPRISING THE SAME Novaled GmbH (DE) 2021-10-27 EP claimed
EP-3643720-B1 ORGANIC COMPOUNDS, ORGANIC SEMICONDUCTOR LAYER AND ORGANIC ELECTRONIC DEVICE NOVALED GMBH (DE) 2021-09-29 EP claimed
WO-2020126972-A1 COMPOUND AND AN ORGANIC SEMICONDUCTING LAYER, AN ORGANIC ELECTRONIC DEVICE AND A DISPLAY DEVICE COMPRISING THE SAME NOVALED GMBH (DE) 2020-06-25 WO claimed
EP-3670504-A1 COMPOUND AND AN ORGANIC SEMICONDUCTING LAYER, AN ORGANIC ELECTRONIC DEVICE AND A DISPLAY DEVICE COMPRISING THE SAME Novaled GmbH (DE) 2020-06-24 EP claimed
EP-3643720-A1 ORGANIC COMPOUNDS, ORGANIC SEMICONDUCTOR LAYER AND ORGANIC ELECTRONIC DEVICE Novaled GmbH (DE) 2020-04-29 EP claimed
EP-4691210-A1 ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING A ORGANIC MATRIX COMPOUND AND ORGANIC ELECTRON TRANSPORT COMPOUND OF FORMULA (I), AND DISPLAY DEVICE COMPRISING THE ORGANIC ELECTROLUMINESCENT DEVICE Novaled GmbH (DE) 2026-02-11 EP disclosed
WO-2024208890-A1 ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING A ORGANIC MATRIX COMPOUND AND ORGANIC ELECTRON TRANSPORT COMPOUND OF FORMULA (I), AND DISPLAY DEVICE COMPRISING THE ORGANIC ELECTROLUMINESCENT DEVICE NOVALED GMBH (DE) 2024-10-10 WO disclosed
EP-4444061-A1 ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING A ORGANIC MATRIX COMPOUND AND ORGANIC ELECTRON TRANSPORT COMPOUND OF FORMULA (I), AND DISPLAY DEVICE COMPRISING THE ORGANIC ELECTROLUMINESCENT DEVICE Novaled GmbH (DE) 2024-10-09 EP disclosed
US-20230200221-A1 LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE CONDENSED CYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-22 US disclosed
EP-3512841-B1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2023-04-26 EP disclosed
US-11447464-B2 Compounds with spirobifluorene-structures MERCK PATENT GMBH (DE) 2022-09-20 US disclosed
EP-3533784-A1 SPIRO BENZOANTHRACENE-FLUORENE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONIC DEVICES, DISPLAYS AND LIGHTING DEVICES Novaled GmbH (DE) 2019-09-04 EP disclosed
EP-3533793-A1 ORGANIC ELECTRONIC DEVICE, DISPLAY AND LIGHTING DEVICES COMPRISING THE SAME Novaled GmbH (DE) 2019-09-04 EP disclosed
EP-3512841-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES Merck Patent GmbH (DE) 2019-07-24 EP disclosed
US-20190194164-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2019-06-27 US disclosed
US-20190194164-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2019-06-27 US disclosed
WO-2018050584-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230200221-A1 LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE CONDENSED CYCLIC COMPOUND CRY1, CRY2, ELP1 ALDH1A1 269/4885HSD17B10 1650/4885MAPK1 1609/4885
US-11447464-B2 Compounds with spirobifluorene-structures SLCO1B3, SLCO4C1, SLCO1B1 ALDH1A1 380/4885HSD17B10 1035/4885MAPK1 2792/4885
US-20190194164-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES SLCO1B3, SLCO4C1, SLCO1B1 ALDH1A1 380/4885HSD17B10 1035/4885MAPK1 2792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.